Iodasept 10% Ointment for wounds and infections 90 g TEVA

Jodasept 10% ointment for wounds and infections Teva is a medicinal product that is available without a prescription. Jodasept 10% Ointment for wounds and infections Teva is recommended for the treatment of bacterially infected wounds, varicose and trophic ulcers, decubitus ulcers, for the treatment of skin burns, postoperative wounds. The product is also suitable for disinfection in first aid for wounds of various nature, for disinfection of the skin around the insertion sites of catheters, drains, probes. Jodasept is suitable for the treatment of purulent skin rashes (pyodermas), skin diseases caused by bacteria and fungi, or superinfections with the same causative agents, of superficial dermatoses.
Before using Jodasept it is good to know:
Do not use Iodacept in the following cases:

Hypersensitivity to the active substance or to any of the excipients;
Hyperthyroidism;
Thyroid adenoma;
Before, during and after radioactive iodine therapy (until complete recovery);
Dermatitis herpetiformis;
Pregnancy and breastfeeding;
Children up to 6 months of age.

Special warnings and precautions for use: Due to the risk of burns with mercuric iodide, povidone-iodine should not be applied simultaneously or sequentially with mercury derivatives. In case of impaired thyroid function, the product should be applied only after consulting a doctor. Caution is required during long-term application on damaged skin in patients with chronic renal failure. In case of prolonged application on large surfaces, especially in burns, or in patients with thyroid disease or newborns and children up to 6 months, it is advisable to examine thyroid function.
Due to the oxidizing effect of povidone-iodine, false-positive results may be obtained in some diagnostic tests (e.g. in the determination of hemoglobin or blood sugar with toluidine or exchange resin). Povidone-iodine may reduce the uptake of iodine by the thyroid gland. This may compromise thyroid studies (scintigraphy, determination of protein-bound iodine, radioactive iodine study) and make radioactive iodine therapy impossible. Scintigraphy should not be performed within 1-2 weeks after treatment with povidone-iodine.
The application of Iodacept to areas covering more than 20% of body surface area is not recommended.
Interaction with other medicinal products and other forms of interaction: Iodine interacts with mercury compounds, forming highly locally toxic (corrosive) mercury iodide. Povidone-iodine exerts its effect at pH values between 2-7. It interacts with proteins and other organic compounds, reducing its effect. 
When used simultaneously with enzymatic wound healing products, the enzymatic component loses its effect. Povidone-iodine should not be combined with taurolidine or hydrogen peroxide (local oxidative processes are enhanced).
Fertility, pregnancy and lactation:
In pregnant women in the first trimester of pregnancy, the product is used with caution. Iodacept 10% ointment should not be used in the second and third trimesters of pregnancy, as well as during lactation due to the possibility of damage to the thyroid gland of the fetus and newborn. The product should be used only when absolutely necessary and after careful assessment of the ratio of expected benefit to the mother/potential risk to the fetus and newborn. Effects on the ability to drive and use machines: Iodacept 10% ointment does not affect the ability to drive and use machines. Adverse drug reactions: Very rarely, hypersensitivity reactions are observed even in patients allergic to iodine. In isolated cases, when applying the product to the wound, pain, burning or a feeling of warmth may occur. Reactions of this type are transient and resolve quickly.
Isolated cases of disturbances in serum electrolytes and osmolarity, metabolic acidosis or renal failure have been observed after prolonged treatment or during application to large surfaces. Measures in case of overdose include discontinuation of the product and, if necessary, symptomatic measures.
If any of the side effects gets serious or you notice any other side effects not listed in this leaflet, please tell your doctor or pharmacist.
 
Active ingredients: povidone-iodine.
Additional ingredients: macrogol 400, macrogol 4000.
 
Iodacept ointment is intended for application to the skin and should not be taken orally or placed in the eyes.
If you are not sure about anything, ask your doctor or pharmacist when using this product.
Adults and children over 6 months:
Usually, Iodasept ointment is applied 2-3 times a day directly to the wound surface or as a dressing applied to sterile gauze. The treated surface should be cleaned and dried beforehand.
For severely inflamed or heavily exuding wounds, the dressing can be renewed every 4-6 hours to achieve the best effect.
The brown color is characteristic of iodine-containing products. It is an indicator of their activity. When the brown color decreases, it is necessary to renew the dressing.
Overdose: In case of local overdose of povidone-iodine, the released iodine may cause skin erosions, necrosis and dermatitis. In case of local overdose of povidone-iodine with massive iodine resorption (e.g. in the treatment of extensive burns), generalized side effects may occur. Single cases of general reactions such as neutropenia, cardiac arrhythmia, disturbances of serum electrolytes and osmolarity, metabolic acidosis, toxic hepatitis, acute renal failure have been reported.
Do not use in case of hypersensitivity to any of the ingredients.
Store in a dry place at temperatures up to 25 degrees.
Keep out of reach of children.